Loading...
XLON
AVG
Market cap366mUSD
Oct 07, Last price  
750.00GBP
1D
0.00%
1Q
19.05%
Jan 2017
288.60%
IPO
933.23%
Name

Avingtrans PLC

Chart & performance

D1W1MN
XLON:AVG chart
P/E
41.02
P/S
1.70
EPS
0.18
Div yield, %
0.65%
Shrs. gr., 5y
0.84%
Rev. gr., 5y
10.64%
Revenues
163m
+4.43%
40,026,00041,247,00037,559,00028,578,00036,260,00043,992,00045,280,00060,265,00022,557,00021,177,00022,714,00078,864,000104,044,00091,961,00098,516,00099,075,000116,437,000136,615,000156,406,000163,340,000
Net income
7m
+2.96%
159,0001,145,0001,128,000607,0001,261,000935,0001,300,0002,914,000-783,000420,000-296,000-4,486,0002,511,0001,386,0003,987,0006,478,0005,194,0003,662,0006,558,0006,752,000
CFO
15m
+26.08%
2,487,0001,160,000-386,0003,518,0002,637,0001,574,000-494,0001,550,0001,646,0007,791,000-3,260,000-6,892,0009,028,000-12,9996,446,0003,706,0009,567,0001,334,00011,611,00014,639,000
Dividend
May 28, 20262 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Avingtrans plc operates as a global provider of specialized engineered products, integrated systems, and technical services, catering to the energy, healthcare, and infrastructure sectors. The company's operations are structured into three distinct divisions: Energy-EPM, Energy-PSRE, and Medical-MII. Avingtrans demonstrates expertise in the design, production, integration, and maintenance of various robust equipment, including electric motors and pumps, steam turbines, gas compressors, heavy-duty pressure vessels, blast-resistant doors, specialized containers, and modular skidded systems. Furthermore, the company develops and manufactures advanced equipment for the scientific and medical communities. This includes components for diagnostic medical devices, high-specification pressure and vacuum vessels, and composite materials tailored for research institutions. They also supply superconducting magnets and helium-free cryogenic systems, which are essential for applications such as Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR). Founded in 1985, Avingtrans plc maintains its headquarters in Chatteris, United Kingdom.

Related entities

Subsidiaries
MAGNETICA LIMITED

Key people

Non-Executive Independent Chairman of the Board · since 2023
Austen Adams
Group Chief Operating Officer, Executive Director · since 2025
Stephen McQuillan
Chief Executive Officer, Executive Director · since 2021
Stephen King
Chief Financial Officer, Company Secretary, Executive Director · since 2010
John Clarke
Non-Executive Independent Director · since 2023
J. Reedman
Non-Executive Independent Director · since 2022
Leslie Thomas
Senior Independent Non-Executive Director · since 2023
IPO date
Dec 08, 2000
Employees
704
Domiciled in
GB
Incorporated in
GB
Headquarters & legal address
CHATTERIS BUSINESS PARK
HONEYSOME ROAD
CHATTERIS, CAM PE16 6SA
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑052025‑052024‑052023‑052022‑052021‑052020‑052019‑052018‑052017‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT